@article{article, title  = {{Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.}},

 publisher = {{Springer Verlag}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/108856 http://doi.org/10.1007/s40273-016-0457-1 }},

 year = {{2016}},

 month = {{10}},

 author = {{Kearns B and Pandor A and Stevenson M and Hamilton J and Chambers D and Clowes M and Graham J and Kumar MS}},

 doi = {{10.1007/s40273-016-0457-1}},

 journal = {{Pharmacoeconomics}},

 note = {{Accessed on 2025/10/31}}}